Sernova Corp.

TSXV Exchange | Jul 8, 2020, 6:41 PM EDT | Real-time price

SVA $ 0.29 RT
-0.02 (-6.4516%)
Day Low: 0.285
Day High: 0.315
Detailed Quote
Open: 0.305
High: 0.315
Beta: 1.4305
Shares Out.: 192,572,614
Total Shares (All Classes)2: 195,945,114
Prev. Close: 0.31
Low: 0.285
VWAP: 0.3017
Escrow Shares: 3,472,500
Market Cap (All Classes)2*: 56,824,083
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: N/A
Listed Shares Out.1: 196,045,114
EPS: -0.04
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: 29.00
Market Cap1: 56,853,083
Exchange: TSXV

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.


Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. It develops a commercially-viable treatment for insulin-dependent human diabetes and other metabolic, blood and neurological diseases with therapeutic cells placed into its implanted, prevascularized and scalable medical device.... More

Info TSX Venture

A comprehensive database of information on TSX Venture issuers

Show all links

Note: as part of an update to TMX Money, this link will be removed on June 30, 2020. Users wishing to access InfoTSXV can continue to do so directly

Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.